1g49: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 20: | Line 20: | ||
==Disease== | ==Disease== | ||
Known disease associated with this structure: Coronary heart disease, susceptibility to OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=185250 185250]] | Known disease associated with this structure: Coronary heart disease, susceptibility to, 6 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=185250 185250]] | ||
==About this Structure== | ==About this Structure== | ||
1G49 is a | 1G49 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1G49 OCA]. | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:11150165</ref><references group="xtra"/> | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Stromelysin 1]] | [[Category: Stromelysin 1]] | ||
[[Category: Almstead, N G.]] | [[Category: Almstead, N G.]] | ||
| Line 39: | Line 38: | ||
[[Category: Zinc protease]] | [[Category: Zinc protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 17:33:58 2009'' | ||
Revision as of 18:33, 17 February 2009
A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3A CARBOXYLIC ACID BASED INHIBITOR IN COMPLEX WITH MMP3
Template:ABSTRACT PUBMED 11150165
DiseaseDisease
Known disease associated with this structure: Coronary heart disease, susceptibility to, 6 OMIM:[185250]
About this StructureAbout this Structure
1G49 is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO. Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines. J Med Chem. 2000 Dec 28;43(26):4948-63. PMID:11150165
Page seeded by OCA on Tue Feb 17 17:33:58 2009